NASDAQ INO

Inovio Stock Soars 300%: First FDA Approval for a DNA Medicine

2026-10-30

Inovio Pharmaceuticals (NASDAQ: INO) stock soared more than 300% in after-hours trading on Friday, October 30, 2026, after the U.S. Food and Drug Administration granted accelerated approval to Voce...